Molina Healthcare Stock Rating Upgraded by Zacks (MOH)
Molina Healthcare (NYSE:MOH) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a report issued on Thursday. The firm currently has a $55.00 target price on the stock. Zacks‘s target price points to a potential upside of 19.51% from the stock’s previous close.
Molina Healthcare (NYSE:MOH) traded up 0.15% on Thursday, hitting $46.02. 250,878 shares of the company’s stock traded hands. Molina Healthcare has a one year low of $31.10 and a one year high of $47.00. The stock has a 50-day moving average of $44.2 and a 200-day moving average of $38.82. The company has a market cap of $2.129 billion and a P/E ratio of 77.62.
Molina Healthcare (NYSE:MOH) last released its earnings data on Thursday, May 1st. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.11. The company had revenue of $2.07 billion for the quarter, compared to the consensus estimate of $2.06 billion. During the same quarter in the previous year, the company posted $0.64 earnings per share. The company’s revenue for the quarter was up 30.1% on a year-over-year basis. On average, analysts predict that Molina Healthcare will post $2.03 earnings per share for the current fiscal year.
MOH has been the subject of a number of other recent research reports. Analysts at Jefferies Group reiterated a “buy” rating on shares of Molina Healthcare in a research note on Thursday. They now have a $54.00 price target on the stock, up previously from $47.00. Separately, analysts at Leerink Swann raised their price target on shares of Molina Healthcare from $40.00 to $45.00 in a research note on Monday, June 30th. Finally, analysts at Sterne Agee initiated coverage on shares of Molina Healthcare in a research note on Friday, June 27th. They set a “buy” rating and a $69.00 price target on the stock. Five investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $47.23.
Molina Healthcare, Inc provides medicaid-related solutions. The Company operates in two segments: Health Plans and Molina Medicaid Solutions.
To view Zacks’ full report, visit Zacks’ official website.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.